The genomics of cancer

Many cancers are associated with changes to our genetic material, DNA. These may be small, single unit substitutions, large rearrangements such as deletions or duplications of a part of the […]

Read More… from The genomics of cancer

Reprogramming the immune system for personalised immunotherapy against cancer

For decades, researchers have strived to understand how the immune system recognises and fights cancer, ultimately aiming to exploit and augment these processes to create more effective cancer therapies. Dr […]

Read More… from Reprogramming the immune system for personalised immunotherapy against cancer

Inhibiting cancer stem cell survival in the hostile tumour environment

Wouldn’t it be great if a small non-toxic molecule could be used to treat cancer? By investigating the possibility of using a cancer cell’s own physiology as a weapon against […]

Read More… from Inhibiting cancer stem cell survival in the hostile tumour environment

A new class of antibiotic drugs

a science article about Dr McMaster’s research which focuses on metabolic regulation with an eye toward the development of therapies for unmet medical needs in the infectious and inherited disease spaces.

Finding new classes of antibiotic drugs could not only save human lives, but also greatly reduce the healthcare costs related to tackling bacteria resistant to currently available drugs. Professor Chris […]

Read More… from A new class of antibiotic drugs

Lysenin channels as single-molecule sensors, controlled nano-valves, and memory elements

This research article covers Prof Fologea’s work which aims to discover more detail on the functionality of lysenin channels.

Professor Daniel Fologea, an associate professor at Boise State University, studies the way cells interact with their environment by selective transportation of ions and molecules through the cell membrane. His research […]

Read More… from Lysenin channels as single-molecule sensors, controlled nano-valves, and memory elements

Extending the half‑life of therapeutic peptides

This article is about Dr Alhamadsheh’s research which combines synthetic organic chemistry with biochemistry and molecular biology to study protein-protein interactions.

Dr Mamoun Alhamadsheh is Associate Professor at the University of the Pacific, Thomas J. Long School of Pharmacy and Health Sciences, California. He heads a multi-disciplinary team working in the […]

Read More… from Extending the half‑life of therapeutic peptides

Pushing the boundaries – interrogating magnetism at material interfaces

this research article covers Dr Holcomb’s work which focuses on the properties of the boundaries of two materials. These are often very different to the properties of the bulk of the material and Dr Holcomb aims to develop methods for studying the boundaries specifically.

In order to keep improving electronic devices, whether it be computers or sensors, researchers must understand what is going on, on an atomic level. Understanding the behaviour of ions within materials […]

Read More… from Pushing the boundaries – interrogating magnetism at material interfaces

Let’s hear it for the proteome

Hearing loss is one of the most common sensory impairments, affecting 250 million people worldwide. The causes of deafness, such as exposure to loud noise, are relatively well known, but […]

Read More… from Let’s hear it for the proteome

The Synapse Neurobiology Training Program, training the next generation of neuroscientists

a research article about The goals of the SNTP are to produce graduates who are exceptional research scientists addressing critical neurological problems of consequence to human health.

Research into the functions of synapses is crucial to understanding the mechanisms of highly prevalent brain disorders such as epilepsy, autism and Alzheimer’s disease. Professor Michele Jacob is the director […]

Read More… from The Synapse Neurobiology Training Program, training the next generation of neuroscientists